Skip to main content

Table 2 Characteristics of patients

From: Direct comparison of brain [18F]FDG images acquired by SiPM-based and PMT-based PET/CT: phantom and clinical studies

Pt.

Clinical diagnosis

Age

Sex

Weight (kg)

Glucose (mg/dL)

Injected dose (MBq)

Uptake duration (min, PMT/SiPM)

1

MCI

72

Male

63.3

96

162.5

40.0/55.6

2

Amnesia

49

Male

73.1

102

151.7

40.0/54.5

3

FTLD

60

Female

63.0

95

149.3

40.0/57.5

4

Juvenile AD

49

Male

89.4

93

168.7

40.0/57.2

5

Juvenile AD

55

Male

65.4

111

172.1

40.0/56.8

6

MCI

70

Female

46.6

90

174.8

40.1/56.6

7

Amnesia, AD

81

Male

55.5

96

165.0

40.0/55.6

8

Dystonia

36

Female

42.9

99

172.2

40.0/54.7

9

Familial AD

55

Female

54.0

96

160.4

40.0/54.5

10

Posterior cortical atrophy

63

Male

61.3

100

140.1

40.0/57.0

Means ± SD

-

59.0 ±13.1

-

61.5 ± 13.3

97.8 ± 5.8

161.7 ±11.4

40.0 ± 0.0/ 56.0 ± 1.2

  1. AD Alzheimer’s disease, FTLD Frontotemporal lobar degeneration, MCI Mild cognitive impairment, PMT Photomultiplier tube, SiPM Silicon photomultiplier